Literature DB >> 16213473

Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography.

Ramin V Parsey1, Justine M Kent, Maria A Oquendo, Misty C Richards, Mali Pratap, Thomas B Cooper, Victoria Arango, J John Mann.   

Abstract

BACKGROUND: In vivo determination of serotonin transporter (5-HTT) occupancy by selective serotonin reuptake inhibitors (SSRI) using positron emission tomography (PET) can aid in determination of dosing. Previous studies used chronic SSRI administration that may down-regulate 5-HTT and used the cerebellum as reference region despite measurable 5-HTT. We examine the reference region and occupancy after acute sertraline dosing.
METHODS: We conducted autoradiography of human postmortem cerebellum to determine an optimal reference region. We quantified 5-HTT binding using [(11)C]DASB and arterial input functions in 17 healthy volunteers. Baseline PET scans were followed by a scan 4-6 days after 25 mg to 100mg of daily sertraline. Several modeling methods and outcome measures were assessed.
RESULTS: Cerebellar gray matter is the optimal reference region. Occupation of 5-HTT sites saturates at low plasma sertraline levels (K(D) = 1.9 ng/ml) with maximal occupancies of 106.8 +/- 8.3% across all brain regions. There is a weak correlation between oral sertraline and plasma sertraline. Occupancy measures vary based on the reference region and outcome measure used.
CONCLUSIONS: Occupancy studies and postmortem autoradiography can help define the optimal reference region. Reference tissue modeling using the optimal reference region returns the same occupancy measures as those determined using an arterial input function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213473     DOI: 10.1016/j.biopsych.2005.08.010

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  52 in total

1.  Increase the dose or give it a few more weeks.

Authors:  Michael S Hanau
Journal:  Psychiatry (Edgmont)       Date:  2007-03

2.  A dose-finding study of duloxetine based on serotonin transporter occupancy.

Authors:  Akihiro Takano; Kazutoshi Suzuki; Jun Kosaka; Miho Ota; Shoko Nozaki; Yoko Ikoma; Shuji Tanada; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2006-02-28       Impact factor: 4.530

Review 3.  Positron emission tomography molecular imaging in late-life depression.

Authors:  Kentaro Hirao; Gwenn S Smith
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-01-05       Impact factor: 2.680

4.  Quantification of Positron Emission Tomography Data Using Simultaneous Estimation of the Input Function: Validation with Venous Blood and Replication of Clinical Studies.

Authors:  Elizabeth A Bartlett; Mala Ananth; Samantha Rossano; Mengru Zhang; Jie Yang; Shu-Fei Lin; Nabeel Nabulsi; Yiyun Huang; Francesca Zanderigo; Ramin V Parsey; Christine DeLorenzo
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

5.  Noninvasive blood-free full quantification of positron emission tomography radioligand binding.

Authors:  Francesca Zanderigo; R Todd Ogden; Ramin V Parsey
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-05       Impact factor: 6.200

6.  Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands.

Authors:  Melanie Ganz; Ling Feng; Hanne Demant Hansen; Vincent Beliveau; Claus Svarer; Gitte M Knudsen; Douglas N Greve
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-11       Impact factor: 6.200

7.  Molecular imaging of serotonin degeneration in mild cognitive impairment.

Authors:  Gwenn S Smith; Frederick S Barrett; Jin Hui Joo; Najlla Nassery; Alena Savonenko; Devin J Sodums; Christopher M Marano; Cynthia A Munro; Jason Brandt; Michael A Kraut; Yun Zhou; Dean F Wong; Clifford I Workman
Journal:  Neurobiol Dis       Date:  2017-05-13       Impact factor: 5.996

8.  Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.

Authors:  Jeffrey M Miller; Natalie Hesselgrave; R Todd Ogden; Gregory M Sullivan; Maria A Oquendo; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2013-03-01       Impact factor: 13.382

9.  Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.

Authors:  Henricus G Ruhé; Jan Booij; Johannes B Reitsma; Aart H Schene
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-30       Impact factor: 9.236

10.  The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men.

Authors:  Elsmarieke van de Giessen; Jan Booij
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-23       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.